Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 35269943 | PubTator, text mining | PubMed |
| Therapeutic Approaches in Adult Primary Spinal Cord Astrocytoma: A Systematic Review. | Cancers (Basel) | 2022 | 35267601 | PubTator, text mining | PubMed |
| Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases. | Cancers (Basel) | 2022 | 35267459 | PubTator, text mining | PubMed |
| Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. | Cancers (Basel) | 2022 | 35267442 | PubTator, text mining | PubMed |
| Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication. | Brain Pathol | 2022 | 35266242 | PubTator, text mining | PubMed |
| Pleomorphic high grade endometrial stromal sarcoma with YWHAE gene amplification may be a novel variant with poor prognosis. | Int J Clin Exp Pathol | 2022 | 35265255 | PubTator, text mining | PubMed |
| Clear cell sarcoma of the kidney in an adult: a case report and literature review. | Transl Cancer Res | 2022 | 35261904 | PubTator, text mining | PubMed |
| BCOR-CCNB3 sarcoma arising in the proximal tibia: A case report. | Mol Clin Oncol | 2022 | 35251628 | PubTator, text mining | PubMed |
| Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial. | Clin Cancer Res | 2022 | 35247906 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the stomach and parotid gland. | Ann Transl Med | 2022 | 35242858 | PubTator, text mining | PubMed |
| High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. | Front Immunol | 2022 | 35242139 | PubTator, text mining | PubMed |
| Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. | Nat Med | 2022 | 35241842 | PubTator, text mining | PubMed |
| Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. | J Immunother Cancer | 2022 | 35241494 | PubTator, text mining | PubMed |
| Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma. | Cancer Sci | 2022 | 35238118 | PubTator, text mining | PubMed |
| A Rare Co-Occurrence of Triple Mutations in JAK2, CALR, and MPL in the Same Patient with Myelofibrosis. | Case Rep Hematol | 2022 | 35237453 | PubTator, text mining | PubMed |
| Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors. | Leuk Lymphoma | 2022 | 35225133 | PubTator, text mining | PubMed |
| The Prognostic Value of Sarcopenia in Acute Myeloid Leukemia Patients and the Development and Validation of a Novel Nomogram for Predicting Survival. | Front Oncol | 2022 | 35223510 | PubTator, text mining | PubMed |
| Cohesin-Mediated Chromatin Interactions and Autoimmunity. | Front Immunol | 2022 | 35222432 | PubTator, text mining | PubMed |
| Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. | Nat Commun | 2022 | 35217640 | PubTator, text mining | PubMed |
| [Fusion-related round and spindle cell sarcomas of the bone (beyond Ewing)]. | Ann Pathol | 2022 | 35216845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=60